food and drug administration fda

FDA bans red dye No. 3

FDA bans Red Dye No. 3 in food and ingested drugs due to cancer risk

The decision came after years of scrutiny and debate over the safety of Red No. 3, particularly concerning its potential impact on children and its alleged link to cancer.

Hosted on MSN · 1d

FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab Rats

After decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food coloring that’s been linked to cancer in male lab rats. The decision comes after a petition filed in 2022 by advocacy groups,

Forbes · 1d

FDA Bans Red Dye 3 On Cusp Of Potentially Big Changes In Food Industry

FDA’s ban on Red 3 is a shot across the bow to the food sector that could ironically help facilitate Kennedy’s pursuit of further changes.

FDA: This common cookware may contaminate your food; here’s why

The U.S. Food & Drug Administration (FDA) would like for people to be aware of the potential risks of using common cooking ...

19hon MSN

FDA orders manufacturers to do a better job detecting bird flu in raw pet food

FDA wants pet food manufacturers to do a better job identifying possible signs of bird flu in raw foods such as uncooked meat ...

1don MSN

Newsweek spoke to experts about the FDA's suggestion to place nutrition information on the front of packaged foods.

21h

AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients

DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...

1don MSN

FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes

The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine ...

1don MSN

FDA approves new MCL treatment by AstraZeneca

WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results